Evidence map›Paper›PMID 38290977›Full record

SynthesisGenome research2024

GenomeMUSter mouse genetic variation service enables multitrait, multipopulation data integration and analysis.

Robyn L Ball, Molly A Bogue, Hongping Liang, Anuj Srivastava, David G Ashbrook, Anna Lamoureux, Matthew W Gerring, Alexander S Hatoum, Matthew J Kim, Hao He and 19 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Genome research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. A New Mouse Model for Ozone Health Effects Research.Environmental health perspectives · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. MVAR: A Mouse Variation Registry.Journal of molecular biology · 2024
    Article
  15. Generalized genetic liability to substance use disorders.The Journal of clinical investigation · 2024
    Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 5 institutions in 3 countries.

Robyn L BallThe Jackson Laboratory, Bar Harbor, Maine 04609, USA; Robyn.Ball@jax.org.ORCID 0000-0002-7335-3339
Molly A BogueThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0000-0001-6624-9261
Hongping LiangThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0009-0009-1115-6725
Anuj SrivastavaThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06032, USA.ORCID 0000-0002-8455-3993
David G AshbrookUniversity of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.ORCID 0000-0002-7397-8910
Anna LamoureuxThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0009-0003-9460-1367
Matthew W GerringThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0000-0002-3820-2869
Alexander S HatoumPsychological and Brain Sciences, Washington University in St. Louis, St. Louis, Missouri 63130, USA.ORCID 0000-0002-8002-7267
Matthew J KimUniversity of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada.ORCID 0009-0008-6792-6699
Hao HeThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.
Jake EmersonThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0000-0003-0617-9219
Alexander K BergerThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0000-0003-4701-4066
David O WaltonThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0000-0002-9848-6808
Keith SheppardThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.
Baha El KassabyThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0000-0003-1381-134X
Francisco CastellanosThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut 06032, USA.ORCID 0009-0002-9789-9595
Govindarajan Kunde-RamamoorthyThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0000-0003-0385-256X
Lu LuUniversity of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.
John BluisThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.
Sejal DesaiThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.
Beth A SundbergThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0000-0002-4261-0750
Gary PeltzDepartment of Anesthesia, Pain and Perioperative Medicine, Stanford University School of Medicine, Stanford, California 94305, USA.ORCID 0000-0001-6191-7697
Zhuoqing FangDepartment of Anesthesia, Pain and Perioperative Medicine, Stanford University School of Medicine, Stanford, California 94305, USA.
Gary A ChurchillThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0000-0001-9190-9284
Robert W WilliamsUniversity of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.ORCID 0000-0001-8924-4447
Arpana AgrawalDepartment of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, USA.ORCID 0000-0002-0313-793X
Carol J BultThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0000-0001-9433-210X
Vivek M PhilipThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0000-0001-5126-707X
Elissa J CheslerThe Jackson Laboratory, Bar Harbor, Maine 04609, USA.ORCID 0000-0002-5642-5062
Jackson Laboratory · USUniversity of Tennessee Health Science Center · USStanford Medicine · USWashington University in St. Louis · USUniversity of British Columbia · CA

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI Mark D ADAMS · 1985 to 2026
$61.9M
Project 5: Circadian RhythmsP50DA039841 · NIDA · JACKSON LABORATORY · PI LAURA G REINHOLDT · 2016 to 2026
$26.2M
The Mutant Mouse Resource and Research Center at The Jackson LaboratoryU42OD010921 · OD · JACKSON LABORATORY · PI Cathleen M Lutz · 2012 to 2026
$21.4M
Use for ResourceP40OD011102 · OD · JACKSON LABORATORY · PI Stephen A Murray · 2012 to 2026
$15.0M
Mouse Phenome ProjectR01DA028420 · NIDA · JACKSON LABORATORY · PI Elissa J Chesler · 2010 to 2026
$9.5M
Computational Methods for Identification of Genetic Factors Affecting the Response to Drug AbuseU01DA044399 · NIDA · STANFORD UNIVERSITY · PI PELTZ, GARY A · 2017 to 2022
$4.7M
Enabling AI-based Mouse Genetic DiscoveryR24OD035408 · OD · STANFORD UNIVERSITY · PI GARY A PELTZ · 2023 to 2026
$3.0M
AI-based genetic discovery for hearing lossR01DC021133 · NIDCD · STANFORD UNIVERSITY · PI GARY A PELTZ · 2023 to 2026
$2.5M
Mass Multivariate Derivation and Validation of AUD Biotypes using Developmental Imaging and Genomic ApproachesK01AA030083 · NIAAA · WASHINGTON UNIVERSITY · PI Alexander S Hatoum · 2022 to 2026
$897k
NCI NIH HHS P30 CA034196NIAAA NIH HHS K01 AA030083NIDA NIH HHS P50 DA039841NIDA NIH HHS R01 DA028420NIDA NIH HHS U01 DA044399NIDCD NIH HHS R01 DC021133NIH HHS P40 OD011102NIH HHS R24 OD035408NIH HHS U42 OD010921
6 · The paper itself

Abstract

Hundreds of inbred mouse strains and intercross populations have been used to characterize the function of genetic variants that contribute to disease. Thousands of disease-relevant traits have been characterized in mice and made publicly available. New strains and populations including consomics, the collaborative cross, expanded BXD, and inbred wild-derived strains add to existing complex disease mouse models, mapping populations, and sensitized backgrounds for engineered mutations. The genome sequences of inbred strains, along with dense genotypes from others, enable integrated analysis of trait-variant associations across populations, but these analyses are hampered by the sparsity of genotypes available. Moreover, the data are not readily interoperable with other resources. To address these limitations, we created a uniformly dense variant resource by harmonizing multiple data sets. Missing genotypes were imputed using the Viterbi algorithm with a data-driven technique that incorporates local phylogenetic information, an approach that is extendable to other model organisms. The result is a web- and programmatically accessible data service called GenomeMUSter, comprising single-nucleotide variants covering 657 strains at 106.8 million segregating sites. Interoperation with phenotype databases, analytic tools, and other resources enable a wealth of applications, including multitrait, multipopulation meta-analysis. We show this in cross-species comparisons of type 2 diabetes and substance use disorder meta-analyses, leveraging mouse data to characterize the likely role of human variant effects in disease. Other applications include refinement of mapped loci and prioritization of strain backgrounds for disease modeling to further unlock extant mouse diversity for genetic and genomic studies in health and disease.

Indexed as

Diabetes Mellitus, Type 2AnimalsGenetic VariationGenotypeHumansMiceMice, Inbred StrainsMutationPhenotypePhylogeny

Identifiers

PMID38290977
PMCPMC10903950
OpenAlexW4391340262

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.